Cargando…

An Alignment-Independent 3D-QSAR Study of FGFR2 Tyrosine Kinase Inhibitors

Purpose: Receptor tyrosine kinase (RTK) inhibitors are widely used pharmaceuticals in cancer therapy. Fibroblast growth factor receptors (FGFRs) are members of RTK superfamily which are highly expressed on the surface of carcinoma associate fibroblasts (CAFs). The involvement of FGFRs in different t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jafari, Behzad, Hamzeh-Mivehroud, Maryam, Alizadeh, Ali Akbar, Sharifi, Mehdi, Dastmalchi, Siavoush
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tabriz University of Medical Sciences 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651062/ https://www.ncbi.nlm.nih.gov/pubmed/29071223 http://dx.doi.org/10.15171/apb.2017.049

Ejemplares similares

Alignment independent 3D-QSAR studies and molecular dynamics simulations for the identification of potent and selective S1P(1) receptor agonists
por: Alizadeh, Ali Akbar, et al.
Publicado: (2020)

Comparison of Different 2D and 3D-QSAR Methods on Activity Prediction of Histamine H3 Receptor Antagonists
por: Dastmalchi, Siavoush, et al.
Publicado: (2012)

In silico Evaluation of Crosslinking Effects on Denaturant m (eq) values and ΔCp upon Protein Unfolding
por: Hamzeh-Mivehroud, Maryam, et al.
Publicado: (2012)

A Simple and Rapid Protocol for Producing Yeast Extract from Saccharomyces cerevisiae Suitable for Preparing Bacterial Culture Media
por: Zarei, Omid, et al.
Publicado: (2016)

Identification of Novel Mutations in Arabidopsis thaliana DOF 4.2 Coding Gene
por: Jamshidi Kandjani, Omid, et al.
Publicado: (2021)

In-silico Investigation of Tubulin Binding Modes of a Series of Novel Antiproliferative Spiroisoxazoline Compounds Using Docking Studies
por: Abolhasani, Hoda, et al.
Publicado: (2015)

Highly efficient novel recombinant L-asparaginase with no glutaminase activity from a new halo-thermotolerant Bacillus strain
por: Safary, Azam, et al.
Publicado: (2019)

Characterization of Novel Fragment Antibodies Against TNF-alpha Isolated Using Phage Display Technique
por: Alizadeha, Ali Akbar, et al.
Publicado: (2019)

Expression and Biological Evaluation of an Engineered Recombinant L-asparaginase Designed by In Silico Method Based on Sequence of the Enzyme from Escherichia coli
por: Dastmalchi, Mahrokh, et al.
Publicado: (2023)

Drug Repurposing for Identification of S1P1 Agonists with Potential Application in Multiple Sclerosis Using In Silico Drug Design Approaches
por: Alizadeh, Ali Akbar, et al.
Publicado: (2023)

A QSAR Study on the 4-Substituted Coumarins as Potent Tubulin Polymerization Inhibitors
por: Dinparast, Leila, et al.
Publicado: (2020)

Characterizing the Hot Spots Involved in RON-MSPβ Complex Formation Using In Silico Alanine Scanning Mutagenesis and Molecular Dynamics Simulation
por: Zarei, Omid, et al.
Publicado: (2017)

6D-QSAR for predicting biological activity of human aldose reductase inhibitors using quasar receptor surface modeling
por: Sokouti, Babak, et al.
Publicado: (2023)

Alignment independent 3D-QSAR, quantum calculations and molecular docking of Mer specific tyrosine kinase inhibitors as anticancer drugs
por: Shiri, Fereshteh, et al.
Publicado: (2016)

Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 Oligodendrocytes
por: Rajendran, Ranjithkumar, et al.
Publicado: (2021)

Alignment-independent technique for 3D QSAR analysis
por: Wilkes, Jon G., et al.
Publicado: (2016)

Expression, Purification and Characterization of Functional Teduglutide Using GST Fusion System in Prokaryotic Cells
por: Alizadeh, Ali Akbar, et al.
Publicado: (2023)

Expression, purification and DNA-binding properties of zinc finger domains of DOF proteins from Arabidopsis thaliana
por: Moghaddas Sani, Hakimeh, et al.
Publicado: (2018)

Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF
por: Shin, Won-Sik, et al.
Publicado: (2019)

Exploration of Novel Inhibitors for Bruton’s Tyrosine Kinase by 3D QSAR Modeling and Molecular Dynamics Simulation
por: Bavi, Rohit, et al.
Publicado: (2016)

Use of QSAR Global Models and Molecular Docking for Developing New Inhibitors of c-src Tyrosine Kinase
por: Ancuceanu, Robert, et al.
Publicado: (2019)

Combinatorial Pharmacophore-Based 3D-QSAR Analysis and Virtual Screening of FGFR1 Inhibitors
por: Zhou, Nannan, et al.
Publicado: (2015)

Rapidly Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in NSCLC Cell Lines through De-Repression of FGFR2 and FGFR3 Expression
por: Ware, Kathryn E., et al.
Publicado: (2010)

FGFR1 tyrosine kinase domain duplication in pilocytic astrocytoma with anaplasia
por: Ballester, Leomar Y., et al.
Publicado: (2018)

SUN-087 FGFR-Selective Tyrosine Kinase Inhibitors, Such as Infigratinib, Show Potency and Selectivity for FGFR3 at Pharmacologically Relevant Doses for the Potential Treatment of Achondroplasia
por: Dobscha, Katherine, et al.
Publicado: (2020)

QSAR Study on a Series of Protein Tyrosine Phosphatase 1B Inhibitors
por: Mehta, Rajendra S., et al.
Publicado: (2008)

3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Dynamics Simulations for the Identification of Spleen Tyrosine Kinase Inhibitors
por: Kumar, Vikas, et al.
Publicado: (2022)

The Receptor Tyrosine Kinase FGFR4 Negatively Regulates NF-kappaB Signaling
por: Drafahl, Kristine A., et al.
Publicado: (2010)

Application of Carbonic Nanosheets Based on Urea Precursors as Dispersive Solid Phase Extraction Adsorbent for Extraction of Methamphetamine from Urine Samples
por: Taghvimi, Arezou, et al.
Publicado: (2021)

Discovery of Novel Naphthoquinone–Chalcone Hybrids as Potent FGFR1 Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling
por: Leechaisit, Ronnakorn, et al.
Publicado: (2023)

Preparation and Antiproliferative Activity Evaluation of Juglone-Loaded BSA Nanoparticles
por: Jahanban-Esfahlan, Ali, et al.
Publicado: (2022)

The Receptor Tyrosine Kinase FGFR2b/KGFR Controls Early Differentiation of Human Keratinocytes
por: Belleudi, Francesca, et al.
Publicado: (2011)

Linear Regression QSAR Models for Polo-Like Kinase-1 Inhibitors
por: Duchowicz, Pablo R.
Publicado: (2018)

SUN-101 Support for a New Therapeutic Approach of Using a Low-Dose FGFR Tyrosine Kinase Inhibitor (Infigratinib) for Achondroplasia
por: Demuynck, Benoit, et al.
Publicado: (2020)

Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
por: Ganji, Mahmoud, et al.
Publicado: (2023)

Modelling the structures of G protein-coupled receptors aided by three-dimensional validation
por: Dastmalchi, Siavoush, et al.
Publicado: (2008)

Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages
por: Amjad, Elham, et al.
Publicado: (2020)

3D QSAR STUDIES ON A SERIES OF QUINAZOLINE DERRIVATIVES AS TYROSINE KINASE (EGFR) INHIBITOR: THE K-NEAREST NEIGHBOR MOLECULAR FIELD ANALYSIS APPROACH
por: Noolvi, Malleshappa N., et al.
Publicado: (2010)

Tyrosine Kinase Inhibitors and Interferon
por: Dimou, Maria, et al.
Publicado: (2014)

Tyrosine Kinase Inhibitors for the Elderly
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rmguaf1qfjbkj0tevj7d0t4bcg